Oseltamivir phosphate (Tamiflu)

ATI-format individual drug card with NCLEX-focused assessment, safety, teaching, and source attribution.

Back to meds
RespiratoryInfectious Diseaseneeds review

Oseltamivir phosphate (Tamiflu)

ATI class: Antiviral / Neuraminidase inhibitor

Action

  • ATI/source-folder candidate for Oseltamivir phosphate (Tamiflu); verify mechanism against the source table before validation.

Therapeutic use

  • Review under Upper Respiratory Tract Disorders medication safety.

Nursing assessment

  • Assess flu symptom onset timing, respiratory status, hydration, renal function, pregnancy status, and immune status.
  • Monitor for worsening shortness of breath, dehydration, confusion, or allergic reaction.
  • Confirm antiviral is being used for viral illness, not bacterial infection.

Administration

  • Verify route against the order and source table.

Side effects

  • Verify common side effects against the source table.

Adverse effects

  • Nausea and vomiting
  • Headache
  • Rare neuropsychiatric symptoms
  • Hypersensitivity

Interactions

  • Live attenuated influenza vaccine timing requires review.
  • Renal impairment may require dose adjustment.
  • Other medications causing neuropsychiatric symptoms may complicate assessment.

Contraindications

  • See source-specific contraindications and precautions before administration.

Precautions

  • Severe hypersensitivity
  • Renal impairment
  • Monitor high-risk clients for worsening respiratory status.

Client teaching

  • Start as soon as possible when prescribed and complete the course.
  • Take with food if nausea occurs.
  • Report breathing difficulty, severe allergic symptoms, confusion, or unusual behavior.

Medication outcomes

  • Therapeutic response with no priority adverse effects.

Antidote / rescue

  • No specific antidote is seeded; hold/question unsafe doses and manage toxicity per provider, facility, or poison-control guidance.

NCLEX priority cues

  • Start antivirals early when prescribed for flu-like illness.
  • Start time-sensitive antivirals early when ordered.
  • Immunocompromised fever or worsening respiratory status is priority.

Medication classes

Antivirals

Source attribution

Google Drive source topic: Upper Respiratory Tract Disorders
google-drive
Sentinel pharmacology API reference
sentinel-api
Manual ATI-format NCLEX candidate normalization
manual-seed

Related study cards

Shows the medication class, ATI cues, source references, and connected study cards for this drug.

12 study links
Med classmedication class
Antivirals

Interferes with viral replication; exact target and timing depend on the antiviral.

ATI cueClass
Antiviral

ATI medication class concept.

ATI cueNursing Assessment
Assess flu symptom onset timing, respiratory status, hydration, renal function, pregnancy status, and immune status.

ATI medication nursing assessment concept.

ATI cueMechanism of Action
ATI/source-folder candidate for Oseltamivir phosphate (Tamiflu); verify mechanism against the source table before validation.

ATI medication mechanism of action concept.

ATI cueNursing Assessment
Confirm antiviral is being used for viral illness, not bacterial infection.

ATI medication nursing assessment concept.

ATI cueAdverse Effect
Headache

ATI medication adverse effect concept.

ATI cueAdverse Effect
Hypersensitivity

ATI medication adverse effect concept.

ATI cueNCLEX Priority Cue
Immunocompromised fever or worsening respiratory status is priority.

ATI medication nclex priority cue concept.

ATI cueInteraction
Live attenuated influenza vaccine timing requires review.

ATI medication interaction concept.

ATI cueNursing Assessment
Monitor for worsening shortness of breath, dehydration, confusion, or allergic reaction.

ATI medication nursing assessment concept.

ATI cuePrecaution
Monitor high-risk clients for worsening respiratory status.

ATI medication precaution concept.

ATI cueAdverse Effect
Nausea and vomiting

ATI medication adverse effect concept.